New perspectives on the role of the intestinal flora in health and disease

Journal of Gastrointestinal and Liver Diseases

Volumn 15, Issue 2, 2006, Pages 109-110

  Quigley, Eamonn M M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; IMMUNOGLOBULIN A; PREBIOTIC AGENT; PROBIOTIC AGENT;

ANAEROBIC BACTERIUM; BACTERIAL COUNT; BACTERIUM CULTURE; BIFIDOBACTERIUM; CLOSTRIDIA; CONFERENCE PAPER; CROHN DISEASE; HOMEOSTASIS; HUMAN; HYPOXIC CELL; IMMUNE RESPONSE; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS; NECROTIZING ENTEROCOLITIS; PSEUDOMEMBRANOUS COLITIS; ULCERATIVE COLITIS; URINARY TRACT INFECTION;

BACTERIA; GASTROINTESTINAL DISEASES; HUMANS; INTESTINES; PROBIOTICS;

EID: 33745755745     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Quigley EMM, Quera R. Small Intestinal Bacterial Overgrowth: Roles of antibiotics, prebiotics and probiotics. Gastroenterology 2006;130(2 Suppl 1):S78-S90.
2. Phillips SF, Quigley EMM, Kumar D and Kamath PS. Motility of the ilcocolonic junction. Gut 1988;29:390-406.
3. Shanahan F. The host-microbe interface within the gut. Best Pract Res Clin Gastroenterol 2002;16:915-931.
4. Guarner F. The intestinal flora in inflammatory bowel disease: normal or abnormal. Curr Opin Gastroenterol 2005;2:414-418.
5. Rachmilewitz D, Katakura K, Karmeli F, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126:520-528.
6. Jijon H, Backer J, Diaz H, et al. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 2004;126:1358-1373.
7. Kamiya T, Wang L, Forsythe P, et al. Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats. Gut 2006;55:191-196.
8. McCarthy J, O'Mahony L, O'Callaghan L, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003;52:975-980.
9. Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003;37:343-350.
10. Sheil B, McCarthy J, O'Mahony L, et al. Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 2004;53:694-700
11. Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003;124:1202-1209.
12. Quigley EMM. The use of probiotics in functional bowel disease. Gastroenterol Clin N Am 2005;34:533-545.
13. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;128:541-51.
14. Whorwell PJ, Altinger L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium Infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006 (in press).